Paper40717455
Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease.
Shehab M and 8 others. Aliment Pharmacol Ther, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease. Papers, record 40717455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40717455
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Network Meta-Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Crohn Disease | Major topic |
| Humans | |
| Adalimumab | |
| Antibodies, Monoclonal, Humanized | |
| Drug Therapy, Combination | |
| Infliximab | |
| Maintenance Chemotherapy | |
| Randomized Controlled Trials as Topic | |
| Remission Induction | |
| Treatment Outcome |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928005 | [KASID Guidelines for the Medical Treatment of Crohn's Disease: 2026]. | Korean J Gastroenterol | 2026 | https://conductscience.org/library/papers/42928005 | PubMed |
| 42835383 | Targeting IL-23p19 in Inflammatory Bowel Disease: The Road Ahead. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42835383 | PubMed |
| 42381756 | Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. | Crohns Colitis 360 | 2026 | https://conductscience.org/library/papers/42381756 | PubMed |
| 42376682 | Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitis. | Crohns Colitis 360 | 2026 | https://conductscience.org/library/papers/42376682 | PubMed |
| 42362204 | Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds. | BMJ Open Gastroenterol | 2026 | https://conductscience.org/library/papers/42362204 | PubMed |
| 42241358 | STRIDE-II treatment target achievement in inflammatory bowel disease: a cross-sectional study from a tertiary IBD centre in the United Arab Emirates. | Saudi J Gastroenterol | 2026 | https://conductscience.org/library/papers/42241358 | PubMed |
| 42240958 | Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/42240958 | PubMed |
| 41745409 | Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions. | J Pers Med | 2026 | https://conductscience.org/library/papers/41745409 | PubMed |
| 41595725 | Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595725 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL23A | 51561 | PubTator's text mining | https://conductscience.org/library/genes/51561 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40717455
GET https://conductscience.org/api/papers/v1/40717455/authors